3,0
24 apr 2015
Dipendente attuale, più di 8 anni
Mosca,
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Innovative company, looking for acquisitions, significant investments in emerging markets, many launches of new products, one of them potential blockbuster in oncology that is breakthrough therapy
Svantaggi
Transformation 3 years in a row, many people left the company, internal initiative on talents doesn't work, prefer hiring outside, competition is not competitive